Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects

NCT02209805 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIRB 796 BS, low dose
DRUG: BIRB 796 BS, high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim